Clinical trials
Risk Reduction clinical trials
Below are recruiting risk reduction clinical trials, each written for real people, not researchers. We’re tracking 63 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06184750RecruitingPhase 2
Finding the best tamoxifen dose to lower breast cancer risk
This trial tests different doses of tamoxifen to find the best one for lowering breast cancer risk in premenopausal women. It aims to see if a lower dose works as well as the standard dose with fewer side effects.
Tucson, ArizonaAges 18–55 - NCT03971669RecruitingPhase 4
Blood donor study testing safety of donating in health
This trial studies people who donate blood and checks what happens in your body after donation, focusing on safety and measurements in lab tests. You may be able to join if you are healthy and pass screening labs and health history checks.
Baltimore, MarylandAges 18 years+ - NCT04294381Recruiting
Behavior goal coaching after heart problems or risk
This study tests whether helping you set and follow your own behavioral health goals (like habits and coping) can improve outcomes after heart-related events or when you have heart symptoms or risk factors. You may be asked to choose goals that matter to you and work on staying on track.
JerusalemAges 18–90 - NCT04932928Recruiting
Using a glucose sensor to improve type 2 diabetes
This study checks whether patient-guided lifestyle changes, supported by a continuous glucose monitor (a sensor), can improve blood sugar control in adults with type 2 diabetes. It may help you and your care team see how food, activity, and habits affect your readings.
SeoulAges 19–80 - NCT05870878Recruiting
Pregnancy planning study for Rotterdam families at higher risk
This study follows women who are planning a pregnancy or are in early pregnancy (under 12 weeks) and have certain risk factors. It aims to help families by testing ways to support children’s healthy development in the Rotterdam area.
RotterdamAges Any age - NCT06195306RecruitingPhase 2
Low dose tamoxifen and omega-3 for breast cancer prevention
This study tests whether low-dose tamoxifen (a breast cancer prevention drug) or omega-3 supplements can lower breast cancer risk in postmenopausal women who are overweight and have a higher chance of getting the disease. The study lasts about 6 months and involves blood draws and a breast fluid test to see how the treatment affects breast cells.
Kansas City, KansasAges 45–74 - NCT06326294Recruiting
Comparing two treatments to reduce cervical cancer risk in women with HIV
This study compares two treatments (Thermal Ablation and LEEP) to lower the risk of cervical cancer in women living with HIV. It aims to find which option works better and is safer for this group.
MaputoAges 25–49 - NCT06413927Recruiting
Driver education study for teen learners in Pennsylvania
This study compares different types of driver training for teens who have a learner's permit. It may help you become a safer driver before you get your license.
Philadelphia, PennsylvaniaAges 16–17 - NCT06424847Recruiting
Sleep and lifestyle changes for inactive adults
This study tests whether a program that combines sleep tips and lifestyle changes can help adults who don't exercise much. It's for people who want to improve their sleep and activity habits.
GrenobleAges 18–80 - NCT06616506Recruiting
AI for cataracts in high myopia
This trial uses artificial intelligence to study cataracts in people with high myopia (very nearsighted). It aims to improve diagnosis and treatment planning for cataract surgery.
Shanghai, Shanghai MunicipalityAges Any age - NCT06618586Recruiting
Social media training for new parents
This study tests if social media can help new parents learn safe sleep practices and reduce infant health risks. You can join if you recently had a healthy baby and plan to care for them at home.
Boston, MassachusettsAges Any age - NCT06785116RecruitingPhase 4
Study on dapagliflozin for heart health after a hypertensive pregnancy
This trial tests a medicine called dapagliflozin (DAPA) to see if it reduces heart risk in women who had high blood pressure or preeclampsia during pregnancy. It is designed for those who had severe blood pressure rises around delivery or a high BNP level, a marker of heart strain.
Ann Arbor, MichiganAges 18 years+ - NCT06818669Recruiting
Heart risk study for Black adults with food insecurity
This study tests if giving small rewards for buying healthy food and taking medicines can lower heart disease risk in African American adults who have trouble getting enough food. You will get help with food costs and health coaching.
Buffalo, New YorkAges 18 years+ - NCT06832761Recruiting
Lifestyle help for people with early memory concerns
This trial tests whether a lifestyle program can help people with mild memory problems (subjective cognitive decline or mild cognitive impairment) who also have at least two things that increase their risk for dementia, like high blood pressure or lack of exercise. If you're 50 or older and have these memory issues and risk factors, you may be able to join.
AmsterdamAges 50 years+ - NCT06839859RecruitingPhase 2
Family Acceptance Project online pilot study
This trial tests an online program called Family Acceptance Project to help LGBTQ+ youth of color and their families improve acceptance and reduce rejection. You and a caregiver will join separate online group sessions to learn communication and support skills.
Ann Arbor, MichiganAges 14 years+ - NCT06926816Recruiting
Genetic testing for cancer risk in young women
This study offers free genetic testing to women ages 25-39 who receive gynecologic care at certain NYU Langone Health clinics. The goal is to find inherited gene changes that may increase risk for ovarian and related cancers, so you can take steps to reduce your risk.
New York, New YorkAges 25–39 - NCT06930885RecruitingPhase 3
Polypill and colchicine for heart and artery risk
This trial tests a combination pill (polypill) and a medicine called colchicine to see if they can lower the risk of future heart attacks, strokes, or other artery problems. It is for people who already have a history of heart or blood vessel disease.
Maceió, AlabamaAges 45 years+ - NCT07024628Recruiting
Heat safety messages from your doctor
This study tests whether health tips sent by text or email from your family doctor can help you stay safe during heat waves. If you live in Eastern Ontario and have a regular primary care provider, you may be able to join and get these messages.
Ottawa, OntarioAges 18 years+ - NCT07326748Recruiting
Lakota Family Acceptance Project for Indigenous LGBTQ+ Youth
This trial tests a program to help Indigenous 2SLGBTQ+ youth and their caregivers improve family acceptance. It involves eight weekly sessions for teens and a parent or guardian.
Pine Ridge, South DakotaAges 13 years+ - NCT07349706Recruiting
Breathing exercise for dementia risk reduction
This trial tests a simple breathing exercise done for about 5–10 minutes each day for 8 weeks. It aims to see if this exercise can reduce your risk of dementia. If you are between 60 and 80 years old and have at least one risk factor for dementia, this study may be a fit for you.
Tallahassee, FloridaAges 60–80 - NCT07442318Recruiting
Healthy pregnancy study in Ethiopia
This study looks at ways to reduce the risk of long-term diseases like diabetes or heart disease in pregnant women in Ethiopia. It focuses on making it easier for women living in four cities to stay healthy during pregnancy.
Addis Ababa, Addis AbabaAges 18 years+ - NCT07612852Recruiting
Digital Health Monitoring Study Using Smartphone App
This 12-month study asks generally healthy people to use a smartphone app and wearable devices (like a fitness tracker) to track their body's health signals. Researchers want to learn how digital tools can help people stay healthy over time.
MessinaAges 18–65 - NCT06959784Enrolling by invitationPhase 4
A study on new diabetes drugs for heart health and remission
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
BeijingAges 30–70 - NCT05889416Enrolling by invitation
Testing a new cardiac rehabilitation program for heart attack patients
This study checks how well a “perfect” version of cardiac rehabilitation (CR) works for people who had a type 1 heart attack. It may help improve follow-up care and outcomes by making CR delivery more consistent.
MalmöAges 18–79
Hear when a new Risk Reduction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for risk reduction?
- Yes. Clin2 currently lists 63 recruiting risk reduction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a risk reduction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a risk reduction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.